EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Use of Benzodiazepines as an Adjuvant in Pain Management: A Narrative Review with Systematic Search

Alexandra da Costa-Duarte, Rita Rodrigues-Lopes, Ana Severino, Matilde Oliveira, Inês Guerra, Mariana Santos, Carolina Damas Pereira, Beatriz Sousa, Pedro Fernandes-Moutinho, Carolina Vilela Teixeira, Gonçalo Silva, Carolina Portela und 6 weitere

BioChem · 30.07.2026 · 6 (3) · 19

DOI: 10.3390/biochem6030019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioChem, online erschienen am 30.07.2026. Verfasst von Alexandra da Costa-Duarte und 17 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, São Paulo Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/objectives: Benzodiazepines are widely prescribed as adjuvants in pain management, particularly for musculoskeletal conditions, with prescription rates for back and chronic pain more than doubling between 2003 and 2015. Yet, the evidence supporting this practice remains poorly defined. This study evaluates the efficacy of benzodiazepines in pain management, analyzing comparative data, pharmacological mechanisms, and global clinical guidelines.

Methods

Narrative review informed by a predefined systematic search of PubMed, Scopus, Cochrane Library and Web of Science. We searched for direct comparative studies between diazepam, alprazolam, and lorazepam in pain management identified no eligible studies, revealing a significant evidence gap despite decades of clinical use. This absence of comparative evidence prompted a broader narrative examination of the evidence base for benzodiazepines across pain conditions.

Results

The available literature consistently fails to support benzodiazepine analgesia. Across 111 chronic pain conditions, analgesic benefit has been demonstrated for only two rare conditions: burning mouth syndrome (evidence primarily for topical clonazepam) and stiff person syndrome (primarily case series and clinical experience). In low back pain, the condition most associated with benzodiazepine prescribing, recent randomized trials show no benefit or even harm compared to placebo, and the only positive pooled evidence derived from trials of tetrazepam, a drug withdrawn from the European market in 2013. In rheumatoid arthritis, pooled data from six small trials show no benefit over placebo at any time point. The pharmacological basis for this clinical failure is now well characterized: conventional non-selective benzodiazepines produce dose-limiting sedation before achieving sufficient receptor occupancy at the α2/α3 GABA-A subtypes responsible for antihyperalgesic effects. Despite the lack of demonstrated efficacy, prescribing persists, likely driven by clinical inertia and patient expectations reflecting anxiolytic rather than analgesic properties. Guidelines from the WHO, NICE, the VA/DoD, the American College of Physicians, the American Academy of Family Physicians, and the Wilderness Medical Society uniformly recommend against benzodiazepine use for pain. This convergence of absent efficacy, well-documented harm, and unanimous guideline opposition supports the conclusion that benzodiazepines should not be prescribed as analgesic adjuvants.

Conclusions

Although the focused search targeted head-to-head trials, a broader narrative synthesis and prior comprehensive reviews likewise demonstrate a paucity of high-quality evidence for benzodiazepine analgesia. Future research should focus on subtype-selective GABA-A modulators and on strategies to align clinical practice with the existing evidence, including structured deprescribing interventions.

Förderung

  • Fundação para a Ciência e Tecnologia
  • São Paulo Research Foundation

Zitieren

APA

Costa-Duarte, A. D., Rodrigues-Lopes, R., Severino, A., Oliveira, M., Guerra, I., Santos, M., Pereira, C. D., Sousa, B., Fernandes-Moutinho, P., Teixeira, C. V., Silva, G., Portela, C., Mendes, D., Araújo, M., Fragão-Marques, M., Rocha-Neves, J., Martins, Í., & Ribeiro, H. (2026). The Use of Benzodiazepines as an Adjuvant in Pain Management: A Narrative Review with Systematic Search. BioChem, 6(3), 19. https://doi.org/10.3390/biochem6030019

Vancouver

Costa-Duarte AD, Rodrigues-Lopes R, Severino A, Oliveira M, Guerra I, Santos M, et al. The Use of Benzodiazepines as an Adjuvant in Pain Management: A Narrative Review with Systematic Search. BioChem. 2026;6(3):19. doi:10.3390/biochem6030019

BibTeX
@article{CostaDuarte2026,
  author = {Costa-Duarte, Alexandra da and Rodrigues-Lopes, Rita and Severino, Ana and Oliveira, Matilde and Guerra, Inês and Santos, Mariana and Pereira, Carolina Damas and Sousa, Beatriz and Fernandes-Moutinho, Pedro and Teixeira, Carolina Vilela and Silva, Gonçalo and Portela, Carolina and Mendes, Duarte and Araújo, Marco and Fragão-Marques, Mariana and Rocha-Neves, João and Martins, Ívis and Ribeiro, Hugo},
  title = {The Use of Benzodiazepines as an Adjuvant in Pain Management: A Narrative Review with Systematic Search},
  journal = {BioChem},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {19},
  doi = {10.3390/biochem6030019}
}
Kostenlos starten →